Work.

Selected work

• AlphaMeld® Operating System

  Live

  alphameld.com
  Compresses hypothesis-to-insight cycles from months to weeks, varying by disease area

  End-to-end AI stack combining a custom UI layer (Knowledge Graph, ChatAlphaMeld, Bioinformatics, Literature Analysis, AlphaClinMeld) with 12 ML models — including NER, RE, evidence scoring, digital-twin CT predictors and landscape assessment — running on PostgreSQL + Neo4j and self-hosted GPT/Claude custom APIs.

• Discovery Navigator

  Early access

  discovery.alphameld.com
  Hypothesis landscaping compressed from weeks to hours, with traceable evidence at every step

  Guided drug-discovery hypothesis-generation platform built on the AlphaMeld Knowledge Graph. Supports four starting points — disease-first, target-first, indication expansion, and combination therapy — through a step-by-step workflow (project → config → exploration → agent scoring → ranking → hypotheses). A project-aware Discovery Copilot accompanies every step. Multi-tenant SaaS with SSO, RBAC, and audit logging.

• ChatAlphaMeld Benchmark Suite

  Research

  inveniai.com
  97.34% accuracy on 188-question ACM benchmark

  Two agentic workflow engines fine-tuned on biomedical tasks; outperformed GPT-4o, GPT-4o-mini, and o3-mini variants; delivered richer step-by-step rationales critical for complex clinical questions.

• SequenceFlow® ResearchNexus & Clinical Navigator

  Live
  6+ integrated modules

  End-to-end AI stack combining Knowledge Graph, Clinical Trial Prediction, Literature Analysis, Patient Digital Twin, TPP, TOP with 12 ML models running on PostgreSQL + Neo4j and self-hosted GPT/Claude custom APIs.

• AlphaCompass Portfolio Intelligence

  Live
  Standardized indication-prioritization across 200 active programs

  Clinical-trial–centric SaaS module on AlphaMeld® graph analytics; benchmarks pipeline assets and quantifies comparative risk. Adopted by two BD teams within six months, standardizing evidence-based indication-prioritization across 200 active programs.

• Clinical-Trial Digital Twins

  Research
  In-silico placebo arms demonstrated for Phase II Type 2 Diabetes trials

  Conditional variational auto-encoder (CVAE) pipeline that synthesizes patient-level digital twins for Phase II Type 2 Diabetes trials. Generated matched placebo trajectories and predicted drug-response curves — proving feasibility of in-silico arms for protocol optimization and hypothesis testing.

• Pipeline Alpha

  Live

  pipelinealpha.com
  Tracks ~10,000 clinical-trial drugs and AI-predicts the catalysts that move small-cap biotech stocks

  Investment research platform for small/mid-cap NASDAQ biotechs where a single trial readout can move the stock 50%+. Syncs clinical-trial data (ClinicalTrials.gov, Clinical Navigator) with live stock and financials (Alpha Vantage), then runs LLM catalyst discovery and streaming AI predictions for upcoming readouts, PDUFA dates, partnerships, and conference events. Includes bulk catalyst briefings and an interactive research chat.

• QuriousRI

  Live

  app.quriousri.com
  Built for Artixio Pvt Ltd
  Drug & biologic regulatory intelligence spanning 12+ agencies — FDA, EMA, PMDA, NMPA, Health Canada, MHRA, Swissmedic, and more

  Secure, role-based platform for pharma/biotech regulatory affairs teams to search, analyze, compare, and manage global drug and biologic approvals. Covers pharmaceuticals, biologics, biosimilars, and generics across 12+ regulators. Combines role-based dashboards, pathway and classification guides, dossier preparation support, a centralized guidelines library, Q&A with expert responses, and AI-assisted document analysis (GPT-4, Claude).

• Secondary Research Automation

  Engagement
  Agent-orchestrated multi-step research, delivered to dashboard or Excel

  Fully agent-orchestrated, multi-step LLM process. Input parameters, run a series of LLM processes to extract information from the web, compile, and store in a dashboard or export to Excel.

• Booking System Platform

  Engagement
  Bespoke booking platform delivered end-to-end to client spec

  End-to-end booking and scheduling platform — custom-built to client specification with real-time availability, notifications, and management dashboard.

• Regulatory Intelligence for ArtiXio

  Live
  Auto-drafts submission dossiers for first-in-class device filings; opened a new non-pharma revenue channel

  AI assistant that mines global regulatory updates and auto-drafts submission dossiers; established a new non-pharma revenue channel.

What I help with